References
- Pathanapitoon K, Tesavibul N, Choopong P, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131(5):638–645. doi:10.1001/jamaophthalmol.2013.2860.
- Chawla R, Venkatesh P, Garg SP, et al. Cytomegalovirus retinitis in a patient with non-Hodgkin’s lymphoma: a diagnostic dilemma. Eur J Ophthalmol. 2005;15(1):153–157. doi:10.1177/112067210501500127.
- Munro M, Yadavalli T, Fonteh C, et al. Cytomegalovirus retinitis in HIV and non-HIV individuals. Microorganisms. 2019;8(1):55. doi:10.3390/microorganisms8010055.
- Ho M, Invernizzi A, Zagora S, et al. Presenting features, treatment and clinical outcomes of cytomegalovirus retinitis: non-HIV patients Vs HIV Patients. Ocul Immunol Inflamm. 2020;28(4):651–658. doi:10.1080/09273948.2019.1604003.
- Bronke C, Palmer NM, Jansen CA, et al. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J Infect Dis. 2005;191(6):873–880. doi:10.1086/427828.
- Holland GN, Van Natta ML, Goldenberg DT, et al. Relationship between opacity of cytomegalovirus retinitis lesion borders and severity of immunodeficiency among people with AIDS. Invest Ophthalmol Vis Sci. 2019;60(6):1853–1862. doi:10.1167/iovs.18-26517.